Dutasteride-based Topical Compositions for Diverse Skin Applications

Publication ID: 24-11857556_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Dutasteride-based Topical Compositions for Diverse Skin Applications,” Published Technical Disclosure No. 24-11857556_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857556_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,556.

Summary of the Inventive Concept

The present inventive concept expands the application of dutasteride-based topical compositions to diverse skin conditions, including wound healing, acne treatment, skin elasticity improvement, and soothing irritated skin, thereby broadening the scope of the original patent.

Background and Problem Solved

The original patent disclosed topical compositions of dutasteride for preventing hair loss and stimulating hair growth. However, the limitations of the original patent lie in its restricted application to hair-related issues. The present inventive concept addresses this limitation by exploring new applications of dutasteride-based topical compositions in various skin conditions, thereby providing a more comprehensive solution for skin health.

Detailed Description of the Inventive Concept

The inventive concept comprises dutasteride-based topical compositions formulated to address specific skin conditions. For instance, a controlled release formulation of dutasteride can be used to reduce inflammation and promote skin regeneration in wounds, burns, or scars. Another embodiment involves combining dutasteride with a retinoid to reduce sebum production and inflammation in acne-prone skin. Additionally, a topical cream comprising dutasteride and aloe vera can be used to soothe and calm irritated skin. Furthermore, a system for promoting wound healing can be developed by combining dutasteride with a growth factor to stimulate cell proliferation and tissue repair.

Novelty and Inventive Step

The novelty of the present inventive concept lies in the unexpected application of dutasteride-based topical compositions to diverse skin conditions, which was not anticipated by the original patent. The inventive step involves the formulation of dutasteride-based compositions to address specific skin conditions, thereby providing a new and non-obvious solution for skin health.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include varying the concentration of dutasteride, combining it with other active ingredients, or using different formulations such as gels, ointments, or patches. Additionally, the inventive concept can be adapted for use in veterinary medicine or as a cosmetic product.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the skincare industry, with potential applications in wound care, acne treatment, skin rejuvenation, and sensitive skin management. The market for skincare products is growing rapidly, and the inventive concept can capitalize on this trend by providing a unique and effective solution for diverse skin conditions.

Field of Art

Pharmaceutical topical formulations, specifically dermatological compositions involving 5α-reductase inhibitors and drug delivery systems for skin treatments

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical formulation scientist with expertise in topical drug delivery, understanding of dermatological conditions, knowledge of active pharmaceutical ingredients, and experience in developing controlled-release compositions

Obviousness Rationale

A PHOSITA would recognize that dutasteride's anti-inflammatory and cell-modulating properties naturally extend beyond hair loss treatment to broader skin conditions. The source patent's foundational composition provides a template for exploring alternative therapeutic applications using similar formulation strategies. The PTD's variations represent predictable extensions of known pharmaceutical design principles applied to a well-characterized compound.

Obvious Combinations & Variations

Source Patent Element
Topical composition containing dutasteride in medium chain triglycerides and ethanol
PTD Variation
Incorporating dutasteride with growth factors for wound healing applications
Obviousness Reasoning
A PHOSITA would recognize that combining active pharmaceutical ingredients to enhance therapeutic outcomes is a standard formulation technique with predictable results
Source Patent Element
0.056 wt% dutasteride concentration for hair growth
PTD Variation
Adjusting dutasteride concentration for different skin condition treatments
Obviousness Reasoning
Dose optimization is a routine practice in pharmaceutical development, representing an obvious design choice for a skilled formulator
Source Patent Element
Topical application method for hair loss treatment
PTD Variation
Expanding application to acne treatment by combining with retinoids
Obviousness Reasoning
Combining known pharmaceutical agents to address related inflammatory conditions represents a standard approach in dermatological research
Source Patent Element
Composition using medium chain triglycerides as a carrier
PTD Variation
Developing controlled-release formulations for extended therapeutic effect
Obviousness Reasoning
Modifying drug delivery mechanisms using known carrier technologies is a predictable engineering solution for pharmaceutical scientists
Source Patent Element
Topical composition for hair growth stimulation
PTD Variation
Creating compositions for skin elasticity and wound healing
Obviousness Reasoning
Exploring alternative therapeutic applications for a known pharmaceutical compound represents a standard investigative approach in medical research
35 U.S.C. § 103 Summary: Based on US Patent 11857556's disclosure of dutasteride topical compositions, the present publication demonstrates that a person of ordinary skill in the art would find the expanded skin treatment applications obvious and predictable, thereby rendering potential claims to such variations unpatentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,556
TitleTopical compositions of dutasteride
Assignee(s)SHILPA MEDICARE LIMITED